Erratum to Presynaptic mechanisms of neuronal plasticity and their role in epilepsy (Frontiers in Cellular Neuroscience, (2014), 8, (164), (10.3389/fncel.2014.00164));Presynaptic mechanisms of neuronal plasticity and their role in epilepsy

Frontiers in Cellular Neuroscience

Volumn 8, Issue JUN, 2014, Pages

  Meier, Jochen ^a   Semtner, Marcus ^a   Winkelmann, Aline ^a   Wolfart, Jakob ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Axon; Epilepsy; Glycine receptor; Hippocampus; Homeostatic regulation; Neuropsy chiatric disorders; Potassium channels; RNA editing

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GLYCINE RECEPTOR; LAMOTRIGINE; LIGAND GATED ION CHANNEL; PHENYTOIN; TOPIRAMATE;

ACTION POTENTIAL; AMINO ACID SUBSTITUTION; ARTICLE; AUTOCRINE EFFECT; EPILEPSY; HIPPOCAMPUS; HOMEOSTASIS AND REGULATION; HUMAN; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARACRINE SIGNALING; PROTEIN BINDING; SYNAPTIC POTENTIAL;

EID: 84902585808     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00206     Document Type: Erratum

References (69)

1. Abbott, L. F., and Nelson, S. B. (2000). Synaptic plasticity: taming the beast. Nat. Neurosci. 3(Suppl), 1178-1183. doi: 10.1038/81453
2. Adams, I. B., and Martin, B. R. (1996). Cannabis: pharmacology and toxicology in animals and humans. Addiction 91, 1585-1614. doi: 10.1046/j.1360-0443.1996.911115852.x
3. Alger, B. E. (2004). Endocannabinoids and their implications for epilepsy. Epilepsy Curr. 4, 169-173. doi: 10.1111/j.1535-7597.2004.04501.x
4. Andrus, M. R., and Gilbert, E. (2010). Treatment of civilian and combat-related posttraumatic stress disorder with topiramate. Ann. Pharmacother. 44, 1810-1816. doi: 10.1345/aph.1P163
5. Barbosa, L., Berk, M., and Vorster, M. (2003). A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J. Clin. Psychiatry 64, 403-407. doi: 10.4088/jcp.v64n0407
6. Bischofberger, J., Engel, D., Frotscher, M., and Jonas, P. (2006). Timing and efficacy of transmitter release at mossy fiber synapses in the hippocampal network. Pflugers Arch. 453, 361-372. doi: 10.1007/s00424-006-0093-2
7. Blair, R. E., Deshpande, L. S., Sombati, S., Falenski, K. W., Martin, B. R., and DeLorenzo, R. J. (2006). Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J. Pharmacol. Exp. Ther. 317, 1072-1078. doi: 10.1124/jpet.105.100354
8. Boison, D. (2012). Adenosine dysfunction in epilepsy. Glia 60, 1234-1243. doi: 10. 1002/glia.22285
9. Boison, D. (2013). Adenosine kinase: exploitation for therapeutic gain. Pharmacol. Rev. 65, 906-943. doi: 10.1124/pr.112.006361
10. Bojnik, E., Turunc, E., Armagan, G., Kanit, L., Benyhe, S., Yalcin, A., et al. (2012). Changes in the cannabinoid (CB1) receptor expression level and G-protein activation in kainic acid induced seizures. Epilepsy Res. 99, 64-68. doi: 10.1016/j.eplepsyres.2011.10.020
11. Catterall, W. A. (1999). Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv. Neurol. 79, 441-456.
12. Chemin, J., Monteil, A., Perez-Reyes, E., Nargeot, J., and Lory, P. (2001). Direct inhibition of T-type calcium channels by the endogenous cannabinoid anan damide. EMBO J. 20, 7033-7040. doi: 10.1093/emboj/20.24.7033
13. Chen, K., Neu, A., Howard, A. L., Foldy, C., Echegoyen, J., Hilgenberg, L., et al. (2007). Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J. Neurosci. 27, 46-58. doi: 10.1523/jneurosci.3966-06.2007
14. Chen, R., Okabe, A., Sun, H., Sharopov, S., Hanganu-Opatz, I. L., Kolbaev, S. N., et al. (2014). Activation of glycine receptors modulates spontaneous epileptiform activity in the immature rat hippocampus. J. Physiol. 592(Pt. 10), 2153-2168. doi: 10.1113/jphysiol.2014.271700
15. Chen, K., Ratzliff, A., Hilgenberg, L., Gulyas, A., Freund, T. F., Smith, M., et al. (2003). Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39, 599-611. doi: 10.1016/s0896-6273(03)00499-9
16. Davis, G. W., and Bezprozvanny, I. (2001). Maintaining the stability of neural function: a homeostatic hypothesis. Annu. Rev. Physiol. 63, 847-869. doi: 10. 1146/annurev.physiol.63.1.847
17. Dias, R. B., Rombo, D. M., Ribeiro, J. A., Henley, J. M., and Sebastiao, A. M. (2013). Adenosine: setting the stage for plasticity. Trends Neurosci. 36, 248-257. doi: 10. 1016/j.tins.2012.12.003
18. Domenici, M. R., Azad, S. C., Marsicano, G., Schierloh, A., Wotjak, C. T., Dodt, H. U., et al. (2006). Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J. Neurosci. 26, 5794-5799. doi: 10.1523/jneurosci.0372-06. 2006
19. Eichler, S. A., Förstera, B., Smolinsky, B., Juttner, R., Lehmann, T. N., Fahling, M., et al. (2009). Splice-specific roles of glycine receptor α3 in the hippocampus. Eur. J. Neurosci. 30, 1077-1091. doi: 10.1111/j.1460-9568.2009.06903.x
20. Eichler, S. A., Kirischuk, S., Jüttner, R., Schäfermeier, P. K., Legendre, P., Lehmann, T. N., et al. (2008). Glycinergic tonic inhibition of hippocampal neurons with depolarising GABAergic transmission elicits histopathological signs of temporal lobe epilepsy. J. Cell. Mol. Med. 12, 2848-2866. doi: 10.1111/j.1582-4934.2008. 00357.x
21. Eichler, S. A., and Meier, J. C. (2008). E-I balance and human diseases-from molecules to networking. Front. Mol. Neurosci. 1:2. doi: 10.3389/neuro.02.002. 2008
22. Förstera, B., Belaidi, A. A., Jüttner, R., Bernert, C., Tsokos, M., Lehmann, T. N., et al. (2010). Irregular RNA splicing curtails postsynaptic gephyrin in the cornu ammonis of patients with epilepsy. Brain 133, 3778-3794. doi: 10. 1093/brain/awq298
23. García-Morales, I., de la Pena, M. P., and Kanner, A. M. (2008). Psychiatric comorbidities in epilepsy: identification and treatment. Neurologist 14, S15-S25. doi: 10.1097/01.nrl.0000340788.07672.51
24. Geiger, J. R., and Jonas, P. (2000). Dynamic control of presynaptic Ca(2+) inflow by fast-inactivating K(+) channels in hippocampal mossy fiber boutons. Neuron 28, 927-939. doi: 10.1016/s0896-6273(00)00164-1
25. Goffin, K., Van, P. W., and Van, L. K. (2011). In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. Brain 134, 1033-1040. doi: 10.1093/brain/awq385
26. Groth, R. D., Lindskog, M., Thiagarajan, T. C., Li, L., and Tsien, R. W. (2011). Beta Ca2+/CaM-dependent kinase type II triggers upregulation of GluA1 to coordinate adaptation to synaptic inactivity in hippocampal neurons. Proc. Natl. Acad. Sci. U S A 108, 828-833. doi: 10.1073/pnas.1018022108
27. Grubb, M. S., and Burrone, J. (2010). Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability. Nature 465, 1070-1074. doi: 10. 1038/nature09160
28. Gu, Y., Barry, J., McDougel, R., Terman, D., and Gu, C. (2012). Alternative splicing regulates kv3.1 polarized targeting to adjust maximal spiking frequency. J. Biol. Chem. 287, 1755-1769. doi: 10.1074/jbc.m111.299305
29. Guggenhuber, S., Monory, K., Lutz, B., and Klugmann, M. (2010). AAV vector mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity. PLoS One 5:e15707. doi: 10.1371/journal.pone.0015707
30. Hill, A. J., Williams, C. M., Whalley, B. J., and Stephens, G. J. (2012). Phytocannabi noids as novel therapeutic agents in CNS disorders. Pharmacol. Ther. 133, 79-97. doi: 10.1016/j.pharmthera.2011.09.002
31. Hofmann, M. E., and Frazier, C. J. (2013). Marijuana, endocannabinoids and epilepsy: potential and challenges for improved therapeutic intervention. Exp. Neurol. 244, 43-50. doi: 10.1016/j.expneurol.2011.11.047
32. Karlócai, M. R., Toth, K., Watanabe, M., Ledent, C., Juhasz, G., Freund, T. F., et al. (2011). Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy. PLoS One 6:e27196. doi: 10. 1371/journal.pone.0027196
33. Katona, I., and Freund, T. F. (2008). Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat. Med. 14, 923-930. doi: 10.1038/nm.f.1869
34. Kawamura, Y., Fukaya, M., Maejima, T., Yoshida, T., Miura, E., Watanabe, M., et al. (2006). The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 26, 2991-3001. doi: 10.1523/jneurosci.4872-05.2006
35. Kirchheim, F., Tinnes, S., Haas, C. A., Stegen, M., and Wolfart, J. (2013). Regulation of action potential delays via voltage-gated potassium Kv1.1 channels in dentate granule cells during hippocampal epilepsy. Front. Cell. Neurosci. 7:248. doi: 10. 3389/fncel.2013.00248
36. Kletke, O., Sergeeva, O. A., Lorenz, P., Oberland, S., Meier, J. C., Hatt, H., et al. (2013). New insights in endogenous modulation of ligand-gated ion channels: Histamine is an inverse agonist at strychnine sensitive glycine receptors. Eur. J. Pharmacol. 710, 59-66. doi: 10.1016/j.ejphar.2013.04.002
37. Kowalczyk, S., Winkelmann, A., Smolinsky, B., Förstera, B., Neundorf, I., Schwarz, G., et al. (2013). Direct binding of GABA(A) receptor β2 and β3 subunits to gephyrin. Eur. J. Neurosci. 37, 544-554. doi: 10.1111/ejn.12078
38. Kubota, H., Alle, H., Betz, H., and Geiger, J. R. (2010). Presynaptic glycine receptors on hippocampal mossy fibers. Biochem. Biophys. Res. Commun. 393, 587-591. doi: 10.1016/j.bbrc.2010.02.019
39. Lawrence, J. J., and McBain, C. J. (2003). Interneuron diversity series: containing the detonation-feedforward inhibition in the CA3 hippocampus. Trends Neurosci. 26, 631-640. doi: 10.1016/j.tins.2003.09.007
40. Legendre, P., Förstera, B., Jüttner, R., and Meier, J. C. (2009). Glycine receptors caught between genome and proteome-functional implications of RNA editing and splicing. Front. Mol. Neurosci. 2:23. doi: 10.3389/neuro.02.023. 2009
41. Lexi-Comp. (2009). Carbamazepine, in The Merck Manual, ed R. S. Porter (Whitehouse Station, N.J., U.S.A: Merck Sharp and Dohme Corp., a subsidiary of Merck and Co., Inc.).
42. Lovett-Barron, M., Kaifosh, P., Kheirbek, M. A., Danielson, N., Zaremba, J. D., Reardon, T. R., et al. (2014). Dendritic inhibition in the hippocampus supports fear learning. Science 343, 857-863. doi: 10.1126/science.1247485
43. Mackie, K., Lai, Y., Westenbroek, R., and Mitchell, R. (1995). Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15, 6552-6561.
44. Meier, J. C., Henneberger, C., Melnick, I., Racca, C., Harvey, R. J., Heinemann, U., et al. (2005). RNA editing produces glycine receptor α3P185L resulting in high agonist potency. Nat. Neurosci. 8, 736-744. doi: 10.1038/nn1467
45. Meier, J., Meunier-Durmort, C., Forest, C., Triller, A., and Vannier, C. (2000). Formation of glycine receptor clusters and their accumulation at synapses. J. Cell Sci. 113, 2783-2795.
46. Meier, J., Vannier, C., Serge, A., Triller, A., and Choquet, D. (2001). Fast and reversible trapping of surface glycine receptors by gephyrin. Nat. Neurosci. 4, 253-260. doi: 10.1038/85099
47. Meyer, G., Kirsch, J., Betz, H., and Langosch, D. (1995). Identification of a gephyrin binding motif on the glycine receptor beta subunit. Neuron 15, 563-572. doi: 10. 1016/0896-6273(95)90145-0
48. Miller, J. W. (2013). Slim evidence for cannabinoids for epilepsy. Epilepsy Curr. 13, 81-82. doi: 10.5698/1535-7597-13.2.81
49. Nicoll, R. A., and Schmitz, D. (2005). Synaptic plasticity at hippocampal mossy fibre synapses. Nat. Rev. Neurosci. 6, 863-876. doi: 10.1038/nrn1786
50. Notelaers, K., Smisdom, N., Rocha, S., Janssen, D., Meier, J. C., Rigo, J. M., et al. (2012). Ensemble and single particle fluorimetric techniques in concerted action to study the diffusion and aggregation of the glycine receptor alpha3 isoforms in the cell plasma membrane. Biochim. Biophys. Acta 1818, 3131-3140. doi: 10. 1016/j.bbamem.2012.08.010
51. Notelaers, K., Rocha, S., Paesen, R., Smisdom, N., De, C. B., Meier, J. C., et al. (2014a). Analysis of alpha3 GlyR single particle tracking in the cell membrane. Biochim. Biophys. Acta 1843, 544-553. doi: 10.1016/j.bbamcr.2013. 11.019
52. Notelaers, K., Rocha, S., Paesen, R., Swinnen, N., Vangindertael, J., Meier, J. C., et al. (2014b). Membrane distribution of the glycine receptor alpha3 studied by optical super-resolution microscopy. Histochem. Cell Biol. doi: 10.1007/s00418-014-1197-y. [Epub ahead of print].
53. Ohno-Shosaku, T., Maejima, T., and Kano, M. (2001). Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729-738. doi: 10.1016/s0896-6273(01) 00247-1
54. Ruiz, A., Campanac, E., Scott, R. S., Rusakov, D. A., and Kullmann, D. M. (2010). Presynaptic GABAA receptors enhance transmission and LTP induction at hippocampal mossy fiber synapses. Nat. Neurosci. 13, 431-438. doi: 10.1038/nn. 2512
55. Stefani, A., Spadoni, F., Siniscalchi, A., and Bernardi, G. (1996). Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur. J. Pharmacol. 307, 113-116. doi: 10.1016/0014-2999(96)00265-8
56. Stegen, M., Kirchheim, F., Hanuschkin, A., Staszewski, O., Veh, R. W., and Wolfart, J. (2012). Adaptive intrinsic plasticity in human dentate gyrus granule cells during temporal lobe epilepsy. Cereb. Cortex 22, 2087-2101. doi: 10. 1093/cercor/bhr294
57. Thiagarajan, T. C., Lindskog, M., and Tsien, R. W. (2005). Adaptation to synaptic inactivity in hippocampal neurons. Neuron 47, 725-737. doi: 10.1016/j.neuron. 2005.06.037
58. Turrigiano, G. (2011). Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu. Rev. Neurosci. 34, 89-103. doi: 10. 1146/annurev-neuro-060909-153238
59. Vogl, C., Mochida, S., Wolff, C., Whalley, B. J., and Stephens, G. J. (2012). The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway. Mol. Pharmacol. 82, 199-208. doi: 10. 1124/mol.111.076687
60. Wang, H., Kunkel, D. D., Schwartzkroin, P. A., and Tempel, B. L. (1994). Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata and dendrites in the mouse brain. J. Neurosci. 14, 4588-4599.
61. Waseem, T. V., and Fedorovich, S. V. (2010). Presynaptic glycine receptors influence plasma membrane potential and glutamate release. Neurochem. Res. 35, 1188-1195. doi: 10.1007/s11064-010-0174-7
62. Weltzien, F., Puller, C., O'Sullivan, G. A., Paarmann, I., and Betz, H. (2012). Distribution of the glycine receptor beta-subunit in the mouse CNS as revealed by a novel monoclonal antibody. J. Comp. Neurol. 520, 3962-3981. doi: 10. 1002/cne.23139
63. Wenzel, H. J., Vacher, H., Clark, E., Trimmer, J. S., Lee, A. L., Sapolsky, R. M., et al. (2007). Structural consequences of Kcna1 gene deletion and transfer in the mouse hippocampus. Epilepsia 48, 2023-2046. doi: 10.1111/j.1528-1167.2007. 01189.x
64. Wilson, R. I., Kunos, G., and Nicoll, R. A. (2001). Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31, 453-462. doi: 10. 1016/s0896-6273(01)00372-5
65. Winkelmann, A., Maggio, N., Eller, J., Caliskan, G., Semtner, M., Häussler, U., et al. (2014). Changes in neural network homeostasis trigger neuropsychiatric symptoms. J. Clin. Invest. 124, 696-711. doi: 10.1172/jci71472
66. Wu, S. P., Tsai, J. J., and Gean, P. W. (1998). Frequency-dependent inhibition of neuronal activity by topiramate in rat hippocampal slices. Br. J. Pharmacol. 125, 826-832. doi: 10.1038/sj.bjp.0702096
67. Wykes, R. C., Heeroma, J. H., Mantoan, L., Zheng, K., MacDonald, D. C., Deisseroth, K., et al. (2012). Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci. Transl. Med. 4:161ra152. doi: 10.1126/scitranslmed.3004190
68. Young, C. C., Stegen, M., Bernard, R., Muller, M., Bischofberger, J., Veh, R. W., et al. (2009). Upregulation of inward rectifier K+ (Kir2) channels in dentate gyrus granule cells in temporal lobe epilepsy. J. Physiol. 587, 4213-4233. doi: 10. 1113/jphysiol.2009.170746
69. Zeilhofer, H. U., Studler, B., Arabadzisz, D., Schweizer, C., Ahmadi, S., Layh, B., et al. (2005). Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. J. Comp. Neurol. 482, 123-141. doi: 10.1002/cne.20349